フィソスティグミンは,遅発性不運動症の治療に用いられる.

The oral dose-effect relationship for fluvoxamine: a fixed-dose comparison against placebo in depressed outpatients.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·1996

A comparison of venlafaxine, trazodone, and placebo in major depression.

Journal of clinical psychopharmacology·1994

A controlled study of mianserin in moderately to severely depressed outpatients.

Psychopharmacology bulletin·1991

A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatients.

The Journal of clinical psychiatry·1990

Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients.

The Journal of clinical psychiatry·1981

Immunoreactive calcitonin in cerebrospinal fluid of man.

Brain research·1980

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

How are testicular functions affected after morphine dependence and withdrawal in rats?

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Exocytosed ATP as a therapeutic target for inflammatory and metabolic diseases.

Frontiers in pharmacology·2026

Cardiac Safety Profile of Ziprasidone: A Real-World Pharmacovigilance Study Using FAERS and Network Toxicology.

Current neuropharmacology·2026

Addiction Specialists' Knowledge About and Assessment Practices for Kratom, Phenibut, and Tianeptine.

Substance use & addiction journal·2026

Extended-release buprenorphine in adults with opioid use disorder involving poppy seed tea: An 18-month retrospective case series.

The American journal on addictions·2026

In vitro toxicity of piperazine derivatives involves mitochondrial dysfunction and microtubule-related changes in neuronal cell models.

BMC pharmacology & toxicology·2026

関連する実験動画

フィソスティグミンは,遅発性不運動症の治療に用いられる.

関連する概念動画

The oral dose-effect relationship for fluvoxamine: a fixed-dose comparison against placebo in depressed outpatients.

A comparison of venlafaxine, trazodone, and placebo in major depression.

A controlled study of mianserin in moderately to severely depressed outpatients.

A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatients.

Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients.

Immunoreactive calcitonin in cerebrospinal fluid of man.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

How are testicular functions affected after morphine dependence and withdrawal in rats?

Exocytosed ATP as a therapeutic target for inflammatory and metabolic diseases.

Cardiac Safety Profile of Ziprasidone: A Real-World Pharmacovigilance Study Using FAERS and Network Toxicology.

Addiction Specialists' Knowledge About and Assessment Practices for Kratom, Phenibut, and Tianeptine.

Extended-release buprenorphine in adults with opioid use disorder involving poppy seed tea: An 18-month retrospective case series.

In vitro toxicity of piperazine derivatives involves mitochondrial dysfunction and microtubule-related changes in neuronal cell models.

関連する実験動画

フィソスティグミンは,遅発性不運動症の治療に用いられる.

関連する概念動画

関連記事